Alumis, Inc. (ALMS)
6.85
-0.36
(-4.99%)
USD |
NASDAQ |
Oct 02, 16:00
6.845
0.00 (0.00%)
After-Hours: 20:00
Alumis Market Cap : 880.26M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 880.26M |
| October 01, 2026 | 926.52M |
| September 30, 2026 | 949.65M |
| September 29, 2026 | 936.80M |
| September 28, 2026 | 920.10M |
| September 25, 2026 | 912.39M |
| September 24, 2026 | 936.80M |
| September 23, 2026 | 956.08M |
| September 22, 2026 | 1.042B |
| September 21, 2026 | 1.015B |
| September 18, 2026 | 998.49M |
| September 17, 2026 | 1.005B |
| September 16, 2026 | 1.020B |
| September 15, 2026 | 1.079B |
| September 14, 2026 | 1.185B |
| September 11, 2026 | 1.180B |
| September 10, 2026 | 1.272B |
| September 09, 2026 | 1.259B |
| September 08, 2026 | 1.360B |
| September 04, 2026 | 1.426B |
| September 03, 2026 | 1.460B |
| September 02, 2026 | 1.330B |
| September 01, 2026 | 1.217B |
| August 31, 2026 | 2.803B |
| August 28, 2026 | 2.876B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.983B |
| August 26, 2026 | 3.035B |
| August 25, 2026 | 3.079B |
| August 24, 2026 | 2.959B |
| August 21, 2026 | 3.106B |
| August 20, 2026 | 2.938B |
| August 19, 2026 | 3.083B |
| August 18, 2026 | 3.197B |
| August 17, 2026 | 3.277B |
| August 14, 2026 | 3.252B |
| August 13, 2026 | 3.137B |
| August 12, 2026 | 3.283B |
| August 11, 2026 | 3.260B |
| August 10, 2026 | 3.503B |
| August 07, 2026 | 3.512B |
| August 06, 2026 | 3.537B |
| August 05, 2026 | 3.450B |
| August 04, 2026 | 3.450B |
| August 03, 2026 | 3.323B |
| July 31, 2026 | 3.594B |
| July 30, 2026 | 3.683B |
| July 29, 2026 | 3.356B |
| July 28, 2026 | 3.439B |
| July 27, 2026 | 3.445B |
| July 24, 2026 | 3.562B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 616.58B |
| Corcept Therapeutics, Inc. | 12.54B |
| Aclaris Therapeutics, Inc. | 613.83M |
| BioAge Labs, Inc. | 302.59M |
| ANI Pharmaceuticals, Inc. | 1.658B |
Market Cap Related Metrics
| PS Ratio | 106.84 |
| Price to Book Value | 1.947 |
| Price | 6.85 |
| Earnings Yield | -55.61% |